INDSWFTLAB

Ind-Swift Laboratories Share PriceInd-Swift Laboratories

₹72.9
2.3 (3.26%)
As on 06 June, 2023 | 08:27 BSE: 532305 NSE: INDSWFTLAB

Ind-Swift Laboratories Performance

Day Range

  • Low
  • High
72.9

52 Week Range

  • Low
  • High
72.9
  • Open Price
  • Previous Close
  • Volume

Start SIP in Ind-Swift Laboratories

Start SIP

Ind-Swift Laboratories Share Price

  • Over 1 Month 10.37%
  • Over 3 Month 15.71%
  • Over 6 Month 13.46%
  • Over 1 Year 18.73%

Ind-Swift Laboratories Key Statistics

P/E Ratio 8.9
PEG Ratio 0
Market Cap Cr 431
Price to Book Ratio 0.6
EPS 9.6
Dividend 0
Relative Strength Index 58.79
Money Flow Index 78.47
MACD Signal 1.84
Average True Range 3.53

Ind-Swift Laboratories Investment Rating

  • Master Rating:
  • Ind-Swift Labs. (Nse) has an operating revenue of Rs. 1,207.31 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 7% is okay, ROE of 6% is fair but needs improvement. The company has a high debt to equity of 110%, which can be a reason to worry. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 15% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Ind-Swift Laboratories Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 290302288272276
Operating Expenses Qtr Cr 234246231219241
Operating Profit Qtr Cr 5656575335
Depreciation Qtr Cr 915161682
Interest Qtr Cr 2222242423
Tax Qtr Cr 39-30014
Net Profit Qtr Cr -31292420-63

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹72.9
2.3 (3.26%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹69.9
  • 50 Day
  • ₹67.17
  • 100 Day
  • ₹65.44
  • 200 Day
  • ₹64.54
  • 20 Day
  • ₹69.4
  • 50 Day
  • ₹65.4
  • 100 Day
  • ₹64.83
  • 200 Day
  • ₹62.85

Ind-Swift Laboratories Resistance and Support

PIVOT
₹71.
Resistance
First Resistance ₹71.6
Second Resistance ₹72.6
Third Resistance ₹73.2
RSI 58.79
MFI 78.47
MACD Single Line 1.84
MACD 1.86
Support
First Resistance ₹70
Second Resistance ₹69.41
Third Resistance ₹68.41

Ind-Swift Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 166,306 10,425,723 62.69
Week 233,880 12,776,886 54.63
1 Month 184,117 10,085,924 54.78
6 Month 97,653 5,663,870 58

Ind-Swift Laboratories Result Highlights

Ind-Swift Laboratories Synopsis

NSE-Medical-Generic Drugs

Ind-Swift Laboratori is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1151.96 Cr. and Equity Capital is Rs. 59.81 Cr. for the Year ended 31/03/2023. Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553.
Market Cap 430
Sales 1,152
Shares in Float 3.43
No of funds 3
Yield
Book Value 0.65
U/D Vol ratio 1.6
LTDebt / Equity 110
Alpha 0.05
Beta 0.69

Ind-Swift Laboratories

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 42%42%42%42%
Foreign Portfolio Investors 0.04%
Individual Investors 29.08%28.97%29.06%29.55%
Others 28.92%28.99%28.94%28.45%

Ind-Swift Laboratories Management

Name Designation
Mr. N R Munjal Chairman & Managing Director
Mr. Himanshu Jain Joint Managing Director
Mr. Rishav Mehta Executive Director
Mr. Sahil Munjal Executive Director
Dr. Ashwani Kumar Vig Independent Director
Mr. Rajinder Kumar Gupta Independent Director
Mr. S P Sharma Independent Director
Ms. Neerja Chathley Independent Woman Director

Ind-Swift Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Ind-Swift Laboratories Corporate Action

Date Purpose Remarks
2023-05-29 Audited Results
2023-02-14 Quarterly Results
2022-11-08 Quarterly Results
2022-08-10 Quarterly Results
2022-05-28 Audited Results

Ind-Swift Laboratories MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Ind-Swift Laboratories FAQs

What is Share Price of Ind-Swift Laboratories ?

Ind-Swift Laboratories share price is ₹72 As on 06 June, 2023 | 08:13

What is the Market Cap of Ind-Swift Laboratories ?

The Market Cap of Ind-Swift Laboratories is ₹430.7 Cr As on 06 June, 2023 | 08:13

What is the P/E ratio of Ind-Swift Laboratories ?

The P/E ratio of Ind-Swift Laboratories is 8.9 As on 06 June, 2023 | 08:13

What is the PB ratio of Ind-Swift Laboratories ?

The PB ratio of Ind-Swift Laboratories is 0.6 As on 06 June, 2023 | 08:13

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number